Lv1
28 积分 2023-11-25 加入
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
22天前
已完结
Rationale for CD40 pathway blockade in autoimmune rheumatic disorders
23天前
已完结
Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease
25天前
已完结
Pilot study of baricitinib for active Sjogren’s syndrome
25天前
已完结
Value of magnetic resonance imaging and sialography of the parotid gland for diagnosis of primary Sjögren syndrome
1个月前
已完结
The value of parotid sialography in the diagnosis and staging of Sjogren's syndrome
1个月前
已关闭
Efficacy of belimumab in Primary Sjögren's syndrome: A systematic review
1个月前
已完结
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
1个月前
已完结
Efficacy and safety of iguratimod combined with methylprednisolone for primary Sjögren's syndrome: a meta-analysis and trial sequential analysis
2个月前
已完结
Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome: A randomized clinical trial
2个月前
已完结
皖公网安备34019202002308
